HBK Investments’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

HBK Investments’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-67,856	Closed	-$725K	–	1127
2019 Q1	$725K	Sell	67,856 -65,344	-49%	-$700K	0.01%	740
2018 Q4	$1.17M	Buy	133,200 +57,700	+76%	+$735K	0.01%	643
2018 Q3	$1.27M	Buy	75,500 +53,584	+244%	+$1.16M	0.01%	657
2018 Q2	$459K	Sell	21,916 -51,084	-70%	-$946K	﹤0.01%	824
2018 Q1	$1.18M	Buy	73,000 +52,823	+262%	+$1.05M	0.01%	587
2017 Q4	$382K	Sell	20,177 -8,623	-30%	-$156K	﹤0.01%	806
2017 Q3	$405K	Buy	+28,800	New	+$261K	﹤0.01%	835
2016 Q3	–	Sell	-37,350	Closed	-$245K	–	1057
2016 Q2	$245K	Buy	+37,350	New	+$264K	﹤0.01%	887

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HBK Investments's SPPI Position: Q2 2019 in Review

HBK Investments sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2019, closing a stake of 67,856 shares — an estimated $725K sold.

HBK Investments first reported a position in SPPI in Q2 2016 and held it in 8 quarters. The position peaked at $1.27M in Q3 2018. 165 funds tracked by Wall St. Rank hold SPPI as of Q2 2019.

HBK Investments reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
HBK Investments sold 67,856 Spectrum Pharmaceuticals Inc shares in Q2 2019, an estimated $725K.
HBK Investments first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and held it in 8 quarters.
HBK Investments's Spectrum Pharmaceuticals Inc position peaked at $1.27M in Q3 2018.
165 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.